We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Slams Boston Scientific for Serious GMP Violations; Could Stall Guidant Deal
FDA Slams Boston Scientific for Serious GMP Violations; Could Stall Guidant Deal
January 27, 2006
The FDA put Boston Scientific on notice last week that the company’s quality management practices are insufficient, with “serious regulatory problems” found at numerous facilities and that the agency stood ready to take action without further notice.